Objectives Cardiovascular complications became a notable cause of morbidity and mortality
in patients with lupus as therapeutic advancements became more efficient at managing …

Objective To determine the baseline (time 0) risk factors associated with the subsequent
occurrence of vascular events in a multiethnic US cohort (LUMINA [LUpus in MInorities …

Cardiovascular disease in patients with systemic lupus erythematosus (SLE) remains one of
the most common causes of death and is caused by several factors, including both …

Objective Venous thrombosis is a relatively frequent and serious complication in systemic
lupus erythematosus (SLE) that has been associated with the presence of antiphospholipid …

Introduction. An increased rate of cardiovascular disease (CVD) has been suggested in
patients with systemic lupus erythematosus (SLE). The risk for myocardial infarction (MI) …

Publisher Summary Cardiovascular morbidity is a major issue in SLE, both in terms of
coronary artery disease and stroke. In the prospective Hopkins Lupus Cohort, the lupus …

Objective Patients with systemic lupus erythematosus (SLE) are significantly more likely to
experience a myocardial infarction or a stroke than age‐matched controls. We compared the …

OBJECTIVE: To evaluate the frequency of cardiovascular (CV) disease risk factor screening
in systemic lupus erythematosus (SLE). METHODS: Medical records of patients from a lupus …

Appropriate cardiovascular disease risk assessment in systemic lupus erythematosus may be
lacking in rheumatology practice Page 1 Clinical and Experimental Rheumatology 2018 …

Vascular damage in systemic lupus erythematosus (SLE) occurs through vasculitis,
premature atherosclerosis, and hypercoagulability (predominantly due to the …